Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary grafts

Journal of Pediatrics

Volumn 134, Issue 3, 1999, Pages 280-286

  Reding, Raymond ^a,b   De Ville De Goyet, Jean ^a,b   Delbeke, Isabelle ^a,b   Sokal, Etienne ^a,b   Jamart, Jacques ^a,b   Janssen, Magda ^a,b   Otte, Jean Bernard ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; OKT 3; STEROID; TACROLIMUS;

ARTERY THROMBOSIS; ARTICLE; BILIARY TRACT DISEASE; CADAVER DONOR; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PORTAL VEIN THROMBOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

EID: 0342732869     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70450-6     Document Type: Article

References (19)

1. 1. de Ville de Goyet J, Hausleithner V, Reding R, Lerut J, Janssen M, Otte JB. Impact of innovative techniques on the waiting list and results in pediatric liver transplantation. Transplantation 1993;56:1130-6.
2. 2. Otte JB. Is it right to develop living related liver transplantation? Do reduced and split livers not suffice to cover the needs? Transpl Int 1995;8:69-73.
3. 3. Reding R. Transplantation hépatique pédiatrique à partir d'un donneur vivant parental: La question éthique. Louvain Med. In press.
4. 4. Emond JC, Heffron TG, Kortz EO, Gonzalez-Vallina R, Contis JC, Black DD, et al. Improved results of living-related liver transplantation with routine application in a pediatric program. Transplantation 1993;55:835-40.
5. 5. Katz SM, Ozaki CF, Monsour HP, Fontenot D, Baumann L, Thomas M, et al. Pediatric living-related and cadaveric liver transplantation: a single center experience. Transplant Proc 1994;26:145-6.
6. 6. Reding R, Wallemacq P, Moulin D, Manicourt D, Lambotte L, Jamart J, et al. Early hepatocyte, endothelial and bile duct cell injury after pediatric liver transplantation from cadaveric or living-related donors. Transplantation 1998;65:681-5.
7. 7. Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996;61:247-52.
8. 8. Malatack JJ, Schaid DJ, Urbach AH, Gartner JC, Zitelli BJ, Rockette H, et al. Choosing a pediatric recipient for orthotopic liver transplantation. J Pediatr 1987;111:479-89.
9. 9. Otte JB, de Ville de Goyet J, Reding R, Van Obbergh L, Veyckemans F, Carlier MA, et al. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int 1998;13:308-18.
10. 10. Reding R, Vraux H, de Ville de Goyet J, Sokal E, de Hemptinne B, Latinne D, et al. Monoclonal antibodies in prophylactic immunosuppression after liver transplantation. A randomized controlled trial comparing OKT3 and anti-IL2 receptor LO-Tact-1. Transplantation 1993;55:534-41.
11. 11. Whitington PF. Living donor liver transplantation: ethical considerations. J Hepatol 1996;24:625-7.
12. 12. Mor E, Schwartz ME, Sheiner PA, Menesses P, Hytiroglou P, Emre S, et al. Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation. Transplantation 1993;56:1399-402.
13. 13. Markus BH, Duquesnoy RJ, Gordon R, Fung JJ, Vanek M, Klintmalm GB, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988; 46:372-7.
14. 14. Gunson BK, Hathaway M, Buckels JAG, Mayer AD, Elias E, McMaster P, et al. HLA matching in liver transplantation: a retrospective analysis. Transplant Proc 1992;24:2434-5.
15. 15. Calmus Y, Hannoun L, Dousset B, Wolff P, Miguet JP, Doffoel M, et al. HLA Class I matching is responsible for the hepatic lesions in recurrent viral hepatitis B after liver transplantation. Transplant Proc 1990;22:2311-3.
16. 16. Alonso EM, Piper JB, Echols G, Thistlethwaite JR, Whitington PF. Allograft rejection in pediatric recipients of living related liver transplants. Transplantation 1996;23:40-3.
17. 17. Davies HS, Pollard S, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989;47:524-7.
18. 18. Singer PA, Siegler M, Whitington PF, Lantos JD, Emond JC, Thistlethwaite JR, et al. Ethics of liver transplantation with living donors. N Engl J Med 1989;321:620-2.
19. 19. Rogiers X, Malago M, Gawad K, Jauch KW, Olausson M, Knoefel WT, et al. In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg 1996;224: 331-9.